<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03346265</url>
  </required_header>
  <id_info>
    <org_study_id>s002</org_study_id>
    <nct_id>NCT03346265</nct_id>
  </id_info>
  <brief_title>Progressive Modular Rebalancing (RMP) System Rehabilitation Combined With Sensory Cues for Rehabilitation of Patients With PD</brief_title>
  <official_title>Progressive Modular Rebalancing (RMP) System Rehabilitation Combined With Sensory Cues for Rehabilitation of Patients With PD: a Randomized, Controlled Trial With Crossover.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, the investigators propose a rehabilitative program for Parkinson'
      disease based on the combination of a neurocognitive method, i.e. visual sensory cues, with a
      neurophysiological method, i.e. RMP, in a randomized controlled trial with cross-over. The
      rationale herein was that the RMP may globally improve patients in terms of trunk control,
      motor performance, muscle tone, endurance and so on, predisposing them to improvement of the
      gait rhythm and automaticity induced by use of the visual external cues.

      The primary aim of this pilot, randomized, controlled, trial with crossover was to establish
      whether a 8-week exercise program focused at improving gait in people with PD was more
      effective than a same-duration program of standard physiotherapy. The secondary aim was to
      evaluate the effect on the disease's severity. At this aims investigators used a quantitative
      3D motion analysis system to evaluate gait parameters and UPDRS-II and UPDR-III and H-Y
      staging to evaluate the severity of the disease.

      The investigators hypothesised that the both exercise programs will improve standard
      physiotherapy, however the proposed program will yield better improvements for the people
      with PD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a pilot, bi-centric, exploratory, randomized, controlled, crossover design with
      blind observer .

      Subjects participated in a baseline assessment session (T0, before rehabilitative treatment),
      followed by random allocation to 8 weeks of rehabilitative treatments (A or B) (T1), followed
      by 1 month of inactivity wash out period. Following this wash-out period, patients who
      received treatment A switched to the treatment B and viceversa. A computerized randomization
      schedule was generated on the computer and held by an investigator not involved in subject
      recruitment or assessment.

      Both clinical (neurological visit and scale administration) and instrumental (gait analysis)
      assessments were carried out 3 times: at baseline before rehabilitative treatment (T0), 4
      weeks (T1, intermediate evaluation) and 8 weeks after rehabilitative treatments (T2, final
      evaluation). Medication was kept constant throughout the trial, and all interventions were
      performed at the same time of day for each patient during ON phase.

      Participants were asked to maintain their pre-enrollment activity level and current
      medication dosage when not in the laboratory.

      Assessors, for both clinical and instrumental evaluations, were blinded to the allocation
      treatment.

      During the inactive condition, participants received usual care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Subjects participated in a baseline assessment session (T0, before rehabilitative treatment), followed by random allocation to 8 weeks of rehabilitative treatments (A or B) (T1), followed by 1 month of inactivity wash out period. Following this wash-out period, patients who received treatment A switched to the treatment B and viceversa. A computerized randomization schedule was generated on the computer and held by an investigator not involved in subject recruitment or assessment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stance phase duration ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>swing phase duration ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>double support phase duration ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>cadence ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>step length normalized for the leg length ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>step length asymmetry ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>step width ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>mean speed ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>maximal arm displacement on the posterior-anterior axis ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>trunk Range of motion ( change )</measure>
    <time_frame>- T0 baseline before rehabilitative treatment (T0) - T1 4 weeks (intermediate evaluation) - T2 8 weeks after rehabilitative treatments</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unified Parkinson's Disease Rating Scale</measure>
    <time_frame>were carried out 3 times: at baseline before rehabilitative treatment (T0), 4 weeks (T1, intermediate evaluation) and 8 weeks after rehabilitative treatments (T2, final evaluation)</time_frame>
    <description>Part I: evaluation of mentation, behavior, and mood
Part II: self-evaluation of the activities of daily life (ADLs) including speech, swallowing, handwriting, dressing, hygiene, falling, salivating, turning in bed, walking, and cutting food
Part III: clinician-scored monitored motor evaluation
Part IV: complications of therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hoehn and Yahr</measure>
    <time_frame>were carried out 3 times: at baseline before rehabilitative treatment (T0), 4 weeks (T1, intermediate evaluation) and 8 weeks after rehabilitative treatments (T2, final evaluation)</time_frame>
    <description>Unilateral involvement only usually with minimal or no functional disability Unilateral involvement only 1.5 - Unilateral and axial involvement
Bilateral or midline involvement without impairment of balance Bilateral involvement without impairment of balance 2.5 - Mild bilateral disease with recovery on pull test
Bilateral disease: mild to moderate disability with impaired postural reflexes; physically independent Mild to moderate bilateral disease; some postural instability; physically independent
Severely disabling disease; still able to walk or stand unassisted Severe disability; still able to walk or stand unassisted
Confinement to bed or wheelchair unless aided Wheelchair bound or bedridden unless aided</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Movement Disorders</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment A consisted in a combined exercise program of 40 min duration RMP (Monari, 2004; Monari et al., 2016) and 20 min duration of gait training with sensory cues.
RMP. RMP protocol was based on lengthening and muscular recruitment exercises by means of complex motor skills involving muscular kinetic chains in lower limbs and trunk. Each session was divided into muscular stretching exercise, aiming to increase step length and rotating trunk movements, and tailored progressive exercise therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment B Conventional physiotherapy was composed of 4 sections of exercises, chiefly oriented to different body structures appropriate to movement (International Classification of Functioning, Disability and Health code): trunk (s760), pelvis (s750), lower extremity (s750), and upper extremity (s730) including shoulder region (s720). Domains focused on were (1) warm-up exercises, (2) trunk mobility exercises, (3) postural stability (b715), and (4) transferring oneself (d420) and changing body positions (d410).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment A combined exercise program and gait training with sensory cues</intervention_name>
    <description>Treatment A consisted in a combined exercise program of 40 min duration RMP</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment B Conventional physiotherapy</intervention_name>
    <description>Conventional physiotherapy was composed of 4 sections of exercises, chiefly oriented to different body structures appropriate to movement (International Classification of Functioning, Disability and Health code)</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of idiopathic PD according to UK bank criteria

          -  Hoehn and Yahr stages 1 to 3.

          -  United Parkinson Disease Rating Scale (UPDRS) gait subscore of 1 or more, no change in
             medication during the study period.

          -  All patients were in a stable drug program and had adapted to their current
             medications for at least 2 weeks.

        Exclusion Criteria:

          -  cognitive deficits (defined as scores of &lt;26 on the Mini-Mental State Examination
             [MMSE]),

          -  moderate or severe depression (defined as scores of &gt;17 on the Beck Depression
             Inventory [BDI]),

          -  orthopedic and other gait-influencing diseases such as arthrosis or total hip joint
             replacement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>76 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariano Serrao, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit√† &quot;La Sapienza di Roma&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Policlinico Italia Srl</name>
      <address>
        <city>Rome</city>
        <state>Lazio</state>
        <zip>00162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR. Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord. 2009 Jan 15;24(1):1-14. doi: 10.1002/mds.22141. Review.</citation>
    <PMID>18946880</PMID>
  </reference>
  <reference>
    <citation>Cassimatis C, Liu KP, Fahey P, Bissett M. The effectiveness of external sensory cues in improving functional performance in individuals with Parkinson's disease: a systematic review with meta-analysis. Int J Rehabil Res. 2016 Sep;39(3):211-8. doi: 10.1097/MRR.0000000000000171. Review.</citation>
    <PMID>27119224</PMID>
  </reference>
  <reference>
    <citation>Westwater-Wood S, Adams N, Kerry R (2010): The use of proprioceptive neuromuscular facilitation in physiotherapy practice Physical Therapy Reviews Vol.15 No.1,p23-27</citation>
  </reference>
  <reference>
    <citation>Kabat H, Knapp ME (1943) The use of prostigmine in the treatment of poliomyelitis. JAMA 122: 989-995.</citation>
  </reference>
  <reference>
    <citation>Hove MJ, Keller PE. Impaired movement timing in neurological disorders: rehabilitation and treatment strategies. Ann N Y Acad Sci. 2015 Mar;1337:111-7. doi: 10.1111/nyas.12615. Review.</citation>
    <PMID>25773624</PMID>
  </reference>
  <reference>
    <citation>Kisner, Carolyn &amp; Colby, Lynn A. (2012):</citation>
  </reference>
  <reference>
    <citation>LEVINE MG, KABAT H. Proprioceptive facilitation of voluntary motion in man. J Nerv Ment Dis. 1953 Mar;117(3):199-211.</citation>
    <PMID>13070034</PMID>
  </reference>
  <reference>
    <citation>Monari G (2004) FNP, Facilitazioni Neurocinetiche Progressive. Elaborazione del concetto Kabat. Edi Ermes.</citation>
  </reference>
  <reference>
    <citation>Monari G (2013) RMP, Riequilibrio Modulare Progressivo. Elaborazione concetto Kabat. Edi Ermes</citation>
  </reference>
  <reference>
    <citation>Richards CL, Malouin F, Bedard PJ, Cioni M. Changes induced by L-DOPA and sensory cues on the gait of parkinsonian patients In: Woollacott M, Horak F, editors. Posture and gait: control mechanisms. XIth International Symposium of the Society for Postural and Gait Research, Portland, May 24-27, 1992. University of Oregon Books; 1992, p. 126-129.</citation>
  </reference>
  <reference>
    <citation>Marek SM, Cramer JT, Fincher AL, Massey LL, Dangelmaier SM, Purkayastha S, Fitz KA, Culbertson JY. Acute Effects of Static and Proprioceptive Neuromuscular Facilitation Stretching on Muscle Strength and Power Output. J Athl Train. 2005 Jun;40(2):94-103.</citation>
    <PMID>15970955</PMID>
  </reference>
  <reference>
    <citation>Sharman MJ, Cresswell AG, Riek S. Proprioceptive neuromuscular facilitation stretching : mechanisms and clinical implications. Sports Med. 2006;36(11):929-39. Review.</citation>
    <PMID>17052131</PMID>
  </reference>
  <reference>
    <citation>McAtee RE, Charland J. Facilitated stretching: assisted and unassisted PNF stretching made easy. 2nd ed. Champaign (IL): Human Kinetics, 1999</citation>
  </reference>
  <reference>
    <citation>Kisner &amp; Colby, p208,(2012)</citation>
  </reference>
  <reference>
    <citation>Kisner &amp; Colby 2012, p208</citation>
  </reference>
  <reference>
    <citation>Nagarwal, A.K., Zutshi K., Ram C.S., Zafar R.(2010). Improvement of hamstring flexibility: A comparison between two PNFstretching techniques. International Journal of Sports Science and Engineering.4 (2010) 1, pp 025-033</citation>
  </reference>
  <reference>
    <citation>Surburg PR, Schrader JW. Proprioceptive neuromuscular facilitation techniques in sports medicine: a reassessment. J Athl Train. 1997 Jan;32(1):34-9.</citation>
    <PMID>16558430</PMID>
  </reference>
  <reference>
    <citation>Feland JB, Marin HN. Effect of submaximal contraction intensity in contract-relax proprioceptive neuromuscular facilitation stretching. Br J Sports Med. 2004 Aug;38(4):E18.</citation>
    <PMID>15273211</PMID>
  </reference>
  <reference>
    <citation>Ford P, McChesney J. Duration of maintained hamstring ROM following termination of three stretching protocols. J Sport Rehabil. 2007 Feb;16(1):18-27.</citation>
    <PMID>17699884</PMID>
  </reference>
  <reference>
    <citation>Nagarwal, A.K., Zutshi K., Ram C.S., Zafar R. (2010). Improvement of hamstring flexibility: A comparison between two PNF stretching techniques. International Journal of Sports Science and Engineering. 4 (2010) 1, pp 025-033.</citation>
  </reference>
  <reference>
    <citation>Kavanagh J, Barrett R, Morrison S. The role of the neck and trunk in facilitating head stability during walking. Exp Brain Res. 2006 Jul;172(4):454-63. Epub 2006 Feb 18.</citation>
    <PMID>16489437</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>November 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>November 19, 2017</last_update_submitted>
  <last_update_submitted_qc>November 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Mariano Serrao</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>progressive modular rebalancing</keyword>
  <keyword>PMR</keyword>
  <keyword>visual sensory cues</keyword>
  <keyword>SC</keyword>
  <keyword>Parkinson Disease</keyword>
  <keyword>Movement Disorders</keyword>
  <keyword>Parkinson rehabilitation</keyword>
  <keyword>neurocognitive method</keyword>
  <keyword>motor performance</keyword>
  <keyword>improving gait</keyword>
  <keyword>physiotherapy</keyword>
  <keyword>3D motion analysis system</keyword>
  <keyword>improvements</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

